Clinical Trial Update: Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating the safety and tolerability of escalating doses of fostamatinib in subjects with stable sickle cell disease, currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Fostamatinib (fostamatinib)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Sickle Cell Disease, Hb-SS Disease | Phase 1 | Status: RECRUITING